Relieve the Pain. Preserve the Nerve.
For patients with chronic low back pain, the SPRINT® PNS System is a first-line treatment designed to deliver significant, sustained relief without the need to destroy nerve tissue.
Before RFA, Think PNS.
Radiofrequency ablation (RFA) is a frequently used treatment option for low back pain. However, ablation may lead to worsening multifidus atrophy, disc degeneration and segmental instability, and many patients require regular retreatment.1 Peripheral nerve stimulation (PNS) relieves pain while preserving the nerve — a low risk, minimally invasive option earlier in the care pathway.
Long-term Efficacy. Strong Patient Preference.
Sustained Pain Relief.
A majority of study participants experienced significant reductions in pain intensity, disability and/or pain interference through at least 14 months following the start of PNS treatment.2
Results for pain intensity shown above, see reference for additional details on reductions in disability and pain interference.
Patient-preferred.
In a survey of 256 patients who had a treatment preference, a majority preferred temporary stimulation (e.g. SPRINT) to radiofrequency ablation.3
Relieve the Pain. Preserve the Nerve.
To learn more, or to reach a SPRINT representative in your area, please call 844.378.9108 or visit SprintPNS.com
REFERENCES:
- Cohen SP, Bhaskar A, Bhatia A, et al. Consensus practice guidelines on interventions for lumbar facet joint pain from a multispecialty, international working group. Regional Anesthesia & Pain Medicine 2020;45:424-467.
- Gilmore CA, Desai MJ, Hopkins TJ, Li S, DePalma MJ, Deer TR, Cohen SP, McGee MJ, Boggs JW. Durability of Relief with Percutaneous Medial Branch PNS for the Treatment of Chronic Axial Low Back Pain. American Society of Pain & Neuroscience Annual Meeting, July 2022.
- Staats P, Deer T, Ottestad E, Erdek M, Spinner D, Gulati A. Understanding the role of patient preference in the treatment algorithm for chronic low back pain: results from a survey-based study. Pain management. 2021 Aug.